Categories: NewsPharmaceutical

Anju to Highlight Newly Launched MA Knowledge at DIA MICC 2024 in London

CHICAGO, Sept. 19, 2024 /PRNewswire/ — Anju, a leading provider of adaptive life sciences software solutions, is pleased to announce its participation as an exhibitor at the upcoming DIA Medical Information & Communications Conference scheduled to take place in London on September 24-25th. DIA MICC brings together medical information professionals for discussions, learning, and practical sessions around improving customer experiences across the industry.

Anju is proud to present MA Knowledge, a state-of-the-art application that offers access to verified and carefully curated medical information content, tailored to meet the unique needs of each field representative. With efficient content filtering and search features, MA Knowledge consistently delivers medical information that matches user profiles and their areas of interest.

“Anju’s commitment to innovation was the driving force behind the development of MA Knowledge,” said Reed McLaughlin, General Manager of Anju’s Medical Affairs Division. “We recognized an opportunity to vastly improve the field representatives’ customer experience by providing quick access to trustworthy, curated information.”

Attendees at DIA MICC 2024 are encouraged to visit Anju at booth 8 to explore their adaptable solutions and discuss how Anju’s best-in-class technology can help to streamline your medical information and scientific communications process. Anju’s team of experts will be on hand to answer questions and discuss how Anju’s solutions can meet the unique needs of your organization.

About Anju:
Anju Software is a customer-first organization providing adaptable life science solutions for clinical research, medical affairs, and data science. TrialMaster, IRMS MAX, and TA Scan, the company’s flagship products, lead the way in reducing complexities in the drug and device discovery and commercialization process. Anju is a portfolio company of Abry Partners serving the worldwide pharmaceutical, biotech and contract research Life Sciences markets.

For media inquiries, please contact:
John F. Kouten
JFK Communications, Inc.
+1 609.241.7352
jfkouten@jfkhealth.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/anju-to-highlight-newly-launched-ma-knowledge-at-dia-micc-2024-in-london-302253584.html

SOURCE Anju Software

Staff

Recent Posts

Restart Life Closes Over-Subscribed Second Tranche Financing

Vancouver, British Columbia--(Newsfile Corp. - December 18, 2025) - Restart Life Sciences Corp. (CSE: HEAL)…

51 minutes ago

BioHarvest Sciences Awarded $1.6 Million USD Grant from the Israeli Innovation Authority to Advance Second-Generation Botanical Synthesis Platform

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - December 18, 2025) - BioHarvest Sciences Inc.…

51 minutes ago

Akanda Corp. Welcomes Momentum Towards Cannabis Reform in the United States

Toronto, Ontario--(Newsfile Corp. - December 18, 2025) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company")…

51 minutes ago

Therma Bright Inc. Investee Company, InStatin Expands its Inhaled Statin Programs to include COPD (Chronic Obstructive Pulmonary Disease) as its Lead Indication.

Includes Asthma in its strategic plans and Strengthens its Team in 2024-2025Toronto, Ontario--(Newsfile Corp. -…

51 minutes ago

Optimi Health Announces Appointment of New Director

Vancouver, British Columbia--(Newsfile Corp. - December 18, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX:…

2 hours ago

Brainomix AI Technology Reveals Efficacy of Novel Neuroprotective Drug Candidate in Severe Acute Ischemic Stroke Patients

Brainomix 360 Stroke imaging was utilized to improve and standardize the grading of baseline stroke…

3 hours ago